259 related articles for article (PubMed ID: 28385776)
1. RSK activation via ERK modulates human colon cancer cells response to PTHrP.
Calvo N; Carriere P; Martin MJ; Gentili C
J Mol Endocrinol; 2017 Jul; 59(1):13-27. PubMed ID: 28385776
[TBL] [Abstract][Full Text] [Related]
2. Involvement of ERK1/2, p38 MAPK, and PI3K/Akt signaling pathways in the regulation of cell cycle progression by PTHrP in colon adenocarcinoma cells.
Calvo N; Martín MJ; de Boland AR; Gentili C
Biochem Cell Biol; 2014 Aug; 92(4):305-15. PubMed ID: 25051885
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
Novoa Díaz MB; Carriere P; Gigola G; Zwenger AO; Calvo N; Gentili C
World J Gastroenterol; 2022 Jul; 28(26):3177-3200. PubMed ID: 36051345
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms associated with PTHrP-induced proliferation of colon cancer cells.
Martín MJ; Calvo N; de Boland AR; Gentili C
J Cell Biochem; 2014 Dec; 115(12):2133-45. PubMed ID: 25053227
[TBL] [Abstract][Full Text] [Related]
5. PTHrP treatment of colon cancer cells promotes tumor associated-angiogenesis by the effect of VEGF.
Calvo N; Carriere P; Martín MJ; Gigola G; Gentili C
Mol Cell Endocrinol; 2019 Mar; 483():50-63. PubMed ID: 30639585
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
7. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone-related peptide regulates matrix metalloproteinase-13 gene expression in bone metastatic breast cancer cells.
Ibaragi S; Shimo T; Iwamoto M; Hassan NM; Kodama S; Isowa S; Sasaki A
Anticancer Res; 2010 Dec; 30(12):5029-36. PubMed ID: 21187486
[TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic targets for growth arrest of colorectal cancer cells exposed to PTHrP.
Martín MJ; Gigola G; Zwenger A; Carriquiriborde M; Gentil F; Gentili C
Mol Cell Endocrinol; 2018 Dec; 478():32-44. PubMed ID: 30009852
[TBL] [Abstract][Full Text] [Related]
10. Calcium-sensing receptor induces proliferation through p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase but not extracellularly regulated kinase in a model of humoral hypercalcemia of malignancy.
Tfelt-Hansen J; Chattopadhyay N; Yano S; Kanuparthi D; Rooney P; Schwarz P; Brown EM
Endocrinology; 2004 Mar; 145(3):1211-7. PubMed ID: 14645111
[TBL] [Abstract][Full Text] [Related]
11. Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells.
Carón RW; Yacoub A; Mitchell C; Zhu X; Hong Y; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P
Cell Cycle; 2005 Mar; 4(3):456-64. PubMed ID: 15655348
[TBL] [Abstract][Full Text] [Related]
12. Ca
Chen W; An P; Quan XJ; Zhang J; Zhou ZY; Zou LP; Luo HS
World J Gastroenterol; 2017 Sep; 23(33):6111-6118. PubMed ID: 28970726
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.
Datta NS; Pettway GJ; Chen C; Koh AJ; McCauley LK
J Bone Miner Res; 2007 Jul; 22(7):951-64. PubMed ID: 17501623
[TBL] [Abstract][Full Text] [Related]
14. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
[TBL] [Abstract][Full Text] [Related]
15. Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway.
You S; Li W; Guan Y
Mol Med Rep; 2018 Mar; 17(3):4203-4212. PubMed ID: 29344654
[TBL] [Abstract][Full Text] [Related]
16. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
[TBL] [Abstract][Full Text] [Related]
17. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
[TBL] [Abstract][Full Text] [Related]
18. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells.
Zhu F; Zykova TA; Kang BS; Wang Z; Ebeling MC; Abe Y; Ma WY; Bode AM; Dong Z
Gastroenterology; 2007 Jul; 133(1):219-31. PubMed ID: 17631144
[TBL] [Abstract][Full Text] [Related]
19. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP
Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134
[TBL] [Abstract][Full Text] [Related]
20. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
